A1C hemoglobin (%) B | 0 day–Adult | DCA Advantage | Normal: < 5.7% Pre-diabetes: 5.7%–6.5% Diabetes: > 6.5% | Normal: < 5.7% Pre-diabetes: 5.7%–6.5% Diabetes: > 6.5% |
Albumin (g/dL) S, P | 0–7 days 8–30 days 1–2 mo 3–5 mo 6–12 mo 1–3 y 4–6 y 7–18 y 19 y–Adult | Vitros 5600 | 2.3–3.8 2.0–4.5 2.0–4.8 2.1–4.9 2.1–4.7 3.4–4.2 3.5–5.2 3.7–5.6 3.5–5.0 | 1.8–3.9 1.8–4.4 1.9–4.2 2.2–4.4 2.2–4.7 3.4–4.2 3.5–5.2 3.7–5.6 3.5–5.0 |
Allergens (KUA/L) S, P | 0 day–Adult | Phadia Immunocap | 0–0.34 | 0–0.34 |
ALP (U/L) S, P | 0–7 days 8–30 days 1–3 mo 4–6 mo 7–12 mo 1–3 y 4–6 y 7–9 y 10–11 y 12–13 y 14–15 y 16–18 y 19 y–Adult | Vitros 5600 | 77–265 91–375 60–360 55–325 60–300 129–291 134–346 156–386 120–488 178–455 116–483 58–237 38–126 | 65–270 65–365 80–425 80–345 60–330 129–291 134–346 156–386 116–515 93–386 62–209 45–116 38–126 |
ALT (U/L) S, P | 1–7 days 8–30 days 1–3 mo 4–6 mo 7–12 mo 1–3 y 4–6 y 7–9 y 10–11 y 12–13 y 14–15 y 16–18 y 19 y–Adult | Vitros 5600 | 6–40 10–40 13–39 12–42 13–45 5–45 10–25 10–35 10–35 10–55 10–45 10–40 21–72 | 7–40 8–32 12–47 12–37 12–41 5–45 10–25 10–35 10–30 10–30 5–30 5–35 9–52 |
Ammonia (umol/L) P | 0–1 days 1–13 y 14 d–17 y 18 y–Adult | Vitros 5600 | 64–107 56–92 21–50 9–33 | 64–107 56–92 21–50 9–33 |
Amylase (U/L) S, P | 0–2 m 3–5 m 6–11 m 1–18 y 19 y–Adult | Vitros 5600 | 0–30 0–50 0–80 30–100 30–110 | 0–30 0–50 0–80 30–100 30–110 |
Anticardiolipin IGA (APL) S | 0 day–Adult | Inova DSX | < 12.0 | < 12.0 |
Anticardiolipin IGG (GPL) S | 0 day–Adult | Inova DSX | < 15.0 | < 15.0 |
Anticardiolipin IGM (MPL) S | 0 day–Adult | Inova DSX | < 12.5 | < 12.5 |
Anti-Saccharomyces cerevisiae antibodies (ASCA) IGA (Units) S | 0 day–Adult | Inova DSX | Negative (0–20) Equivocal (20.1–24.9) Positive (> 24.9) | Negative (0–20) Equivocal (20.1–24.9) Positive (> 24.9) |
Anti-Saccharomyces cerevisiae antibodies (ASCA) IGG (Units) S | 0 day–Adult | Inova DSX | Negative (0–20) Equivocal (20.1–24.9) Positive (> 24.9) | Negative (0–20) Equivocal (20.1–24.9) Positive (> 24.9) |
AST (U/L) S, P | 0–7 days 8–30 days 1–3 mo 4–6 mo 7–12 mo 1–3 y 4–6 y 7–9 y 10–11 y 12–15 y 16–18 y 19 y–Adult | Vitros 5600 | 30–100 20–70 22–63 13–65 25–55 20–60 15–50 15–40 10–60 15–40 15–45 17–59 | 24–95 24–72 20–64 20–63 22–63 20–60 15–50 15–40 10–40 10–30 5–30 14–36 |
Bilirubin direct (mg/dL) S, P | 0–30 days > 1 mo | Vitros 5600 | 0–0.6 0–0.3 | 0–0.6 0–0.3 |
Bilirubin total (mg/dL) S, P | 0–1 days 1–3 days 3–30 days > 1 mo | Vitros 5600 | 0.1–5.8 0.1–8.5 0.1–11.5 0.2–1.2 | 0.1–5.8 0.1–8.5 0.1–11.5 0.2–1.2 |
Bilirubin indirect (mg/dL) S, P | 0–30 d | Vitro 5600 | 0–0.6 0–0.3 | 0–0.6 0–0.3 |
BNP (ng/L) Whole blood (Purple) | 0 d–Adult | I–STAT | 0–99 | 0–99 |
Pro-BNP, (pg/mL) S, P | 0 d–Adult | Vitros 5600 | 0–125 | 0–125 |
BUN (mg/dL) S, P | 0–7 days 8–30 days 1–3 mo 4–6 mo 7–12 mo 1–3 y 4–13 y 14–18 y 19 y–Adult | Vitros 5600 | 2–13 2–16 2–12 1–14 2–14 5–17 7–17 8–21 9–21 | 2–13 2–15 2–14 1–13 2–13 5–17 7–17 8–21 7–17 |
C3 (mg/dL) S, P | 0–1 mo 1–2 mo 2–3 mo 3–4 mo 4–5 mo 5–6 mo 6–9 mo 9–11 mo 11–12 mo 1–2 y 2–3 y 3–5 y 5–8 y 8–10 y 10–19 y > 19 y | Vitros 5600 | 55–129 61–155 67–136 64–182 67–174 77–178 78–173 76–187 87–181 84–177 80–178 89–173 92–161 93–203 86–184 88–165 | 55–129 61–155 67–136 64–182 67–174 77–178 78–173 76–187 87–181 84–177 80–178 89–173 92–161 93–203 86–184 88–165 |
C4 (mg/dL) S, P | 0–1 mo 1–2 mo 2–3 mo 3–4 mo 4–5 mo 5–6 mo 6–9 mo 9–11 mo 11–12 mo 1–2 y 2–3 y 3–5 y 5–8 y 8–10 y 10–19 y > 19 y | Vitros 5600 | 9.2–33 9.7–37 11–35 11–50 9.3–47 11–55 12–48 16–51 16–52 12–45 13–47 17–42 16–42 13–52 10–40 14–44 | 9.2–33 9.7–37 11–35 11–50 9.3–47 11–55 12–48 16–51 16–52 12–45 13–47 17–42 16–42 13–52 10–40 14–44 |
Ca (mg/dL) S, P | 0–8 days 8–30 days 1–3 mo 3–6 mo 6–12 mo 1–4 y 4–10 y 10–12 y 12–14 y 14–16 y 16–19 y > 19 y | Vitros 5600 | 7.3–11.4 8.6–11.7 8.5–11.3 8.3–11.4 7.7–11.0 8.7–9.8 8.8–10.1 8.9–10.1 8.8–10.6 9.2–10.7 8.9–10.7 8.4–10.2 | 7.5–11.3 8.4–11.9 8.0–11.1 7.7–11.5 7.8–11.1 8.7–9.8 8.8–10.1 8.9–10.1 8.8–10.6 9.2–10.7 8.9–10.7 8.4–10.2 |
iCa (ionized calcium) (mmol/L) B | 0–3 days 3–4 days 4–8 days 8 d–2 mo 2 mo–18 y > 18 y | RapidLab 1265 or Nova pHOx Ultra | 1.1–1.4 1.1–1.5 1.2–1.5 1.3–1.6 1.2–1.4 1.2–1.3 | 1.1–1.4 1.1–1.5 1.2–1.5 1.3–1.6 1.2–1.4 1.2–1.3 |
iCa/iMg ratio B | 0 d–Adult | Nova pHOx Ultra (Calculated) | 1.90–2.28 | 1.90–2.28 |
Chloride (mmol/L) S, P | 0–8 days 8 d–6 mo 6–12 mo 1–19 y > 19 y | Vitros 5600 | 96–111 96–110 96–108 96–109 98–107 | 96–111 96–110 96–108 96–109 98–107 |
Cholesterol (mg/dL) S, P | 0 d–2 mo 2–7 mo 7–12 mo 1–2 y 2–18 y > 18 y | Vitros 5600 | 45–177 60–197 89–208 44–181 < 170 < 190 | 63–198 66–218 74–218 44–181 < 170 < 190 |
Creatine kinase (U/L) S, P | 0–3 mo 3–12 mo 1–2 y 2–11 y 11–15 y 15–19 > 19 y | Vitros 5600 | 28–300 24–170 27–160 30–150 30–150 33–145 55–170 | 48–470 26–240 24–175 24–175 30–170 27–140 30–135 |
Creatinine (mg/dL) S, P | 0–3 days 3–10 days 10–17 days 17 d–1 y 1–11 y 11–18 y > 18 y | Vitros 5600 | 0.33–1.08 0.14–0.90 0.14–0.61 0.14–0.52 0.23–0.61 0.42–0.90 0.71–1.18 | 0.33–1.08 0.14–0.90 0.14–0.61 0.14–0.52 0.23–0.61 0.42–0.90 0.52–0.99 |
GGT (U/L) S, P | 0–8 days 8–30 days 1–4 mo 4–7 mo 7–12 mo 1–4 y 4–7 y 7–10 y 10–12 y 12–14 y 14–16 y 16–19 y > 19 y | Vitros 5600 | 25–148 23–153 17–130 8–83 10–35 5–16 8–18 11–21 14–25 14–37 10–28 9–29 15–73 | 19–131 17–124 17–124 15–109 10–54 5–16 8–18 11–21 14–23 12–21 12–22 9–23 12–43 |
Glucose (mg/dL) S, P | 0–30 days > 1 mo | Vitros 5600 | 40–80 60–105 | 40–80 60–105 |
Glucose (2-h tolerance test) (mg/dL) S, P | 0 day–Adult | Vitros 5600 | < 200 | < 200 |
Glucose–CSF (mg/dL) CSF | 0 day–Adult | Vitros 5600 | 40–75 | 40–75 |
HDL (mg/dL) S, P | 0 d–2 y 2–18 y 18–Older | Vitros 5600 | 8–61 > 45 > 45 | 8–61 > 45 > 45 |
Beta–2 Glycoprotein 1 Antibody, IgA (SAU) S | 0 day–Adult | Inova DSX | 0–20 | 0–20 |
Beta–2 Glycoprotein 1 Antibody, IgG (SGU) S | 0 day–Adult | Inova DSX | 0–20 | 0–20 |
Beta–2 Glycoprotein 1 Antibody, IgG (SMU) S | 0 day–Adult | Inova DSX | 0–20 | 0–20 |
IgA (mg/dL) S, P | 0–30 days 1–6 mo 6–12 mo 1–4 y 4–7 y 7–10 y 10–13 y 13–16 y 16–19 y > 19 y | Vitros 5600 | 0–11 0–40 1–82 9–137 44–187 58–204 46–218 29–251 68–259 70–400 | 0–10 0–42 6–68 15–111 33–146 28–180 55–193 62–241 69–262 70–400 |
IGE (kU/L) S | 0–12 mo 1–2 y 2–3 y 3–10 y 10 y–Adult | Phadia ImmunoCap | 0–29 0–49 0–45 0–52 0–87 | 0–29 0–49 0–45 0–52 0–87 |
IgG (mg/dL) S, P | 0–30 days 1–6 mo 6–12 mo 1–4 y 4–7 y 7–10 y 10–13 y 13–16 y 16–19 y > 19 y | Vitros 5600 | 197–833 140–533 130–823 413–1112 468–1328 582–1441 685–1620 590–1600 522–1703 700–1600 | 136–872 311–664 325–647 421–1202 560–1319 485–1473 586–1609 749–1640 804–1817 700–1600 |
IgM (mg/dL) S, P | 0–30 days 1–6 mo 6–12 mo 1–4 y 4–7 y 7–10 y 10–13 y 13–16 y 16–19 y > 19 y | Vitros 5600 | 0–65 0–84 15–117 30–146 31–151 21–140 27–151 26–184 28–179 40–230 | 0–57 0–127 0–130 35–184 42–184 30–165 42–211 34–225 42–224 40–230 |
Iron (μg/dL) S, P | 0–7 days 7 d–1 y 1–10 y > 10 y | Vitros 5600 | 100–250 40–100 50–120 49–181 | 100–250 40–100 50–120 37–170 |
Iron-binding capacity (mcg/dL) S | 0 day–Adult | Vitros 5600 | 261–462 | 265–497 |
LDH (U/L) S, P | 0–1 mo 1–4 mo 4–7 mo 7–12 mo 1–4 y 4–7 y 7–10 y 10–12 y 12–14 y 14–16 y 16–18 y > 18 y | Vitros 5600 | 550–2100 480–1220 400–1230 380–1200 500–920 470–900 420–750 432–700 470–750 360–730 340–670 313–618 | 580–2000 460–1150 460–1150 460–1060 500–920 470–900 420–750 380–700 380–640 390–580 340–670 313–618 |
LDL measured (mg/dL) S, P | 0 day–Adult | Vitros 5600 | < 100 | < 100 |
Lead screen (mcg/dL) Whole Blood–Purple Top | 0 day–Adult | Leadcare | < 10 | < 10 |
Magnesium (mg/dL) S, P | 0–7 days 7–30 days 1 mo–2 y 2–6 y 6–10 y 10–14 y > 14 y | Vitros 5600 | 1.2–1.6 1.6–2.4 1.6–2.6 1.5–2.4 1.6–2.3 1.6–2.2 1.5–2.3 | 1.2–1.6 1.6–2.4 1.6–2.6 1.5–2.4 1.6–2.3 1.6–2.2 1.5–2.3 |
iMg (ionized magnesium) (mmol/L) B | 0 day–Adult | Nova pHOx Ultra | 0.45–0.60 | 0.45–0.60 |
Non-HDL cholesterol (mg/dL) S, P | 02 y–Adult | Vitros 5600 (Calculated) | < 120 | < 120 |
Potassium (mmol/L) S, P | 0–7 days 7 d–3 mo 3 mo–18 y > 18 y | Vitros 5600 | 3.7–5.9 4.1–5.3 3.4–4.7 3.5–5.0 | 3.7–5.9 4.1–5.3 3.4–4.7 3.5–5.0 |
Prealbumin (mg/dL) S, P | 0–1 mo 1–6 mo 6 mo–4 y 4–6 y 6–14 y 14–19 y > 19 y | Vitros 5600 | 7–22 8–34 7–32 12–30 12–42 22–45 17–42 | 7–22 8–34 7–32 12–30 12–42 22–45 17–42 |
Phosphorus (mg/dL) S, P | 0–6 mo 7 mo–2 y 2–13 y >13 y | Vitros 5600 | 5.0–8.0 4.5–6.7 4.5–5.5 2.7–4.5 | 5.0–8.0 4.5–6.7 4.5–5.5 2.7–4.5 |
Procalcitonin (ng/mL) P | 0 day–Adult | Biomeriux MiniVidas | 0–0.5 | 0–0.5 |
Sodium (mmol/L) S, P | 0–8 days 8–30 days 1–6 mo 6–12 mo 1–19 y > 19 y | Vitros 5600 | 133–146 134–144 134–142 133–142 134–143 137–145 | 133–146 134–144 134–142 133–142 134–143 137–145 |
Troponin I (ng/mL) S, P | 0 day–Adult | Vitros 5600 | < 0.12 | < 0.12 |
Total protein (g/dL) S, P | 0–2 mo 2–6 mo 6–12 mo 1–4 y 4–7 y 7–10 y 10–20 y > 20 y | Vitros 5600 | 3.9–7.6 4.1–7.9 3.9–7.9 5.9–7.0 5.9–7.8 6.2–8.1 6.3–8.6 6.2–8.2 | 3.4–7.0 3.9–7.6 4.5–7.8 5.9–7.0 5.9–7.8 6.2–8.1 6.3–8.6 6.2–8.2 |
Triglycerides (mg/dL) S, P | 0–9 y 10–18 y Adult | Vitros 5600 | < 75 < 90 < 115 | < 75 < 90 < 115 |
TCO2-Bicarb (mmol/L) S, P | 0–7 days 7–30 days 1–6 mo 6–12 mo 1–19 y > 19 | Vitros 5600 | 17–26 17–27 17–29 18–29 20–31 22–30 | 17–26 17–27 17–29 18–29 20–31 22–30 |
Uric acid (mg/dL) S, P | 0–30 days 1–12 mo 1–10 y 10–12 y 12–14 y 14–16 y 16–18 y > 18 y | Vitros 5600 | 2.0–5.2 2.5–9.0 1.8–5.0 2.3–5.4 2.7–6.7 2.4–7.8 4.0–8.6 3.5–8.5 | 2.0–5.2 2.5–9.0 1.8–5.0 3.0–4.7 3.0–5.9 3.0–5.9 3.0–5.9 2.5–7.5 |
Vitamin B12 (pg/mL) S, P | 0 day–Adult | Vitro 5600 | 163–949 | 163–949 |